Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016) - Battisti, A.; Salpini, R.; Colagrossi, L.; Alteri, C.; Pollicita, M.; Ricciardi, A.; Cerva, C.; Maffongelli, G.; Lichtner, M.; Mastroianni, C.; Casinelli, K.; Paoloni, M.; et al.